Fig. 7From: Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS databaseComparison of PT signal intensity in SOCs associated with three anti-HER-2 agentsBack to article page
